Stocktube video
11/02/2011

Peter Blezard, of Plant Impact, says the company has a lot of unlocked value

View full size
Additional Information
Market: AIM
Sector: Pharmaceuticals & Biotechnology
EPIC: PIM
Latest Price: 17.00p  (3.03% Ascending)
52-week High: 35.25p
52-week Low: 14.50p
Market Cap: 8.56M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Plant Impact
www.plantimpact.com

Plant Impact's range of crop nutrition products focus on crop enhancement. They improve crop performance and crop health giving growers increased marketable yields, better quality and longer shelf life with reduced environmental impact.

Pdf

Plant Impact raises further £1.455 mln via placing to accelerate growth plans

2nd Jul 2009, 10:35 am Plant Impact raises further £1.455 mln via placing to accelerate growth plans

Novel pesticides and plant nutritional products developer Plant Impact PLC (AIM: PIM) said it has agreed a placing of 4,850,000 new ordinary shares at 30 pence each, raising £1.455 million before expenses.

The company plans to use the money to accelerate its growth plans, and in particular to finance further development and testing of its range of nutrient products, to finance field trials and to recruit sales staff. The technical sales team will be expanded with the aim of increasing direct sales in the 15 countries where the group's products are already being sold and supporting the Arysta LifeScience Corp sales effort.

Chief executive Peter Blezard commented: “With the continuing and strong support of our current shareholders and the confidence shown in the company by new investors we will apply this growth plan fundraising to further develop the company's commercial potential. “

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.